natgillin/translations-raw huggingface dataset:
This will depend on, for example: which other medicines your child has already taken for HIV which medicines your child’s HIV is resistant to.
To bo na primer odvisno od tega: katera druga zdravila proti virusu HIV je vaš otrok že jemal, proti katerim zdravilom je HIV pri vašem otroku odporen.
This will ensure that the cells can be eliminated before they can cause damage to the patient’s cells.
S tem se zagotovi, da se celice uničijo, preden poškodujejo bolnikove celice.
This will expose a plastic spiked end that you will use to pierce the vial.
Pokazala se bo plastična konica, s katero prebodete vialo.
This will give you more details on exactly what medicines you cannot take with MULTAQ),
Tam boste našli več podrobnosti o tem, katerih zdravil ne smete jemati hkrati z zdravilom MULTAQ).
This will happen more often in patients with kidney problems.
Bolj pogosti pregledi delovanja ledvic so potrebni pri tistih, ki imajo težave z ledvicami.
This will help keep the test 13C-urea solution in your stomach.
To bo pomagalo zadrževati testno raztopino 13C- sečnine v želodcu.
This will help prevent dehydration.
Pitje bo pomagalo preprečiti dehidracijo.
This will help prevent leakage of Byetta, keep out air bubbles, reduce needle clogs, and decrease the risk of infection.
To bo preprečilo iztekanje zdravila Byetta, nastanek zračnih mehurčkov, zmanjšalo zamaške v igli in zmanjšalo tveganje za infekcijo.
This will help protect the chickens against ND and MD.
To pomaga zaščititi piščance pred boleznijo Newcastle in Marekovo boleznijo.
This will help protect the pigs against porcine circovirus and Mycoplasma hyopneumoniae infections.
Ta odziv bo pripomogel pri zaščiti prašiča pred prašičjim cirkovirusom in okužbami z bakterijo Mycoplasma hyopneumoniae.
This will help protect the pigs against porcine circovirus and Mycoplasma hyopneumoniae infections.
Tako bodo prašiči zaščiteni proti okužbam s prašičjim cirkovirusom in bakteriji Mycoplasma hyopneumoniae.
This will help protect them against the disease.
Ta mu bodo pomagala pri obrambi pred boleznijo.
This will help protect you from stomach problems when taking Imatinib medac.
Tako boste laže preprečili težave z želodcem, do katerih pride pri jemanju zdravila Imatinib medac.
This will help protect you from stomach problems when taking Imatinib Teva
Tako boste laže preprečili težave z želodcem, do katerih pride pri jemanju zdravila Imatinib Teva.
This will help reduce foaming (lots of bubbles) (see Diagram 7).
Tako boste zmanjšali penjenje raztopine (nastajanje mehurčkov) (glejte sliko 7).
This will help to protect against diseases caused by these viruses.
Ta mu bodo pomagala pri obrambi pred boleznimi, ki jih ti virusi povzročajo.
This will help to protect you against sunburn.
To vam bo pomagalo, da se boste obvarovali pred sončnimi opeklinami.
This will help to reduce foaming (lots of bubbles).
Tako boste zmanjšali penjenje raztopine (nastajanje mehurčkov) (glejte sliko 8).
This will help to stop soreness.
S tem boste preprečili bolečino.
This will help you get the correct dose of medicine.
To vam bo omogočilo prejetje pravilnega odmerka.
This will help you grip the pen better and tap it more firmly against your palm.
To vam bo pomagalo, da boste peresnik bolje držali in boste z njim odločneje trkali ob dlan.
This will help your doctor to decide if the dose of the sulfonylurea needs to be changed.
Tako se bo vaš zdravnik lažje odločil, če morate spremeniti odmerek sulfonilsečnine.
This will improve your immune system and reduce the risk of developing illnesses linked to HIV infection.
S tem se vaš imunski sistem izboljša in zmanjša se tveganje za razvoj bolezni, povezanih z okužbo z virusom HIV.
This will include a thorough medical evaluation including your child’s medical history and appropriate screening tests (for example chest X-ray and a tuberculin test).
To bo vključevalo natančno zdravniško oceno vključno s poizvedbo o zdravju vašega otroka v preteklosti in ustrezne preiskave (npr. rentgensko slikanje prsnih organov in tuberkulinski test).
This will include a thorough medical evaluation including your medical history and appropriate screening tests (for example chest X-ray and a tuberculin test).
To bo vključevalo natančno zdravniško oceno vključno s poizvedbo o vašem zdravju v preteklosti in ustrezne preiskave (rentgensko slikanje prsnih organov in tuberkulinski test).
This will include a thorough medical evaluation including your medical history and appropriate screening tests (for example, chest X-ray and a tuberculin test).
To bo vključevalo natančno zdravniško oceno, vključno s poizvedbo o vašem zdravju v preteklosti, in ustrezne preiskave (rentgensko slikanje prsnih organov in tuberkulinski test).
This will include a thorough medical history, a chest X-ray and a tuberculin test.
To vključuje temeljit pregled vaših predhodnih bolezni, rentgensko slikanje prsnega koša in tuberkulinski test.
This will increase the risk of severe infections vincristine, another cancer medicine.
živa cepiva v 3 mesecih po zaključku zdravljenja levkemije, saj lahko povečajo tveganje za hudo okužbo, vinkristin (drugo zdravilo za raka).
This will inject the full dose.
Tako si boste injicirali celoten odmerek.
This will insert the needle and start your injection (See Figure K).
S tem se igla vstavi in začne injiciranje (glejte sliko K).
This will keep the Omnitrope solution sterile and prevent leaking.
Tako bo raztopina zdravila Omnitrope ostala sterilna in ne bo odtekala.
This will lessen the chance for ribavirin to be left in the woman’s body.
Tako boste zmanjšali možnost za prehajanje ribavirina v telo ženske.
This will lessen the chance for ribavirin to be left in the woman’s body.
Tako boste zmanjšali nevarnost za prehajanje ribavirina v telo ženske.
This will lessen the chance for ribavirin to be left in the woman’s body.
To bo zmanjšalo možnost, da ribavirin ostane v ženskem telesu.
This will lessen the possibility for ribavirin to be left in the woman’s body.
S tem se zmanjša možnost vnosa ribavirina v žensko telo.
This will lessen the possibility for ribavirin to be left in the woman’s body.
Tako boste zmanjšali možnost za prehajanje ribavirina v telo ženske.
This will lessen the possibility for ribavirin to be left in the woman’s body.
Tako boste zmanjšali potencialno nevarnost za prehajanje ribavirina v telo ženske.
This will make sure that the bottle adapter and child safety bottle cap are in the right position.
Tako bosta nastavek za steklenico in za otroke varna zaporka pravilno nameščena.
This will make sure that the bottle adapter fits in the bottle in the right position.
To bo zagotovilo, da bo nastavek za steklenico v pravilnem položaju.
This will make sure you get your full dose.
Tako boste zagotovili, da boste dobili poln odmerek.
This will mix the medicine powder and liquid in the clear cartridge.
To bo zmešalo prašek z zdravilom in tekočino v prozornem vložku.
This will push the air that you have just drawn up into the syringe into the solvent vial.
S tem boste v vialo z vehiklom iztisnili zrak, ki ste ga prej potegnili v brizgo.
This will push the water in the syringe into the powder vial.
S tem boste v vialo s praškom iztisnili vodo iz brizge.
This will put all of the medicine back up into the vial.
S tem boste zdravilo v celoti iztisnili nazaj v vialo.
This will release most of the air in the pre-filled pen and is called ‘priming’.
S tem boste sprostili večino zraka iz napolnjenega injekcijskega peresnika in to imenujemo priprava peresnika.
This will result in a fluctuation in the apparent volume of distribution of total active substance but the volume of distribution of free active substance does not change.
To vodi v fluktuacijo navideznega volumna porazdelitve celokupne učinkovine, volumen porazdelitve proste učinkovine pa se ne spreminja.
This will strengthen your immune system and reduce the risk of developing illnesses linked to HIV infection
To bo okrepilo vaš imunski sistem in zmanjšalo tveganje za razvoj bolezni, povezanih z okužbo z virusom HIV.
This will take 30-45 minutes.
To bo trajalo 30-45 minut.
This will take approximately one hour unless otherwise stated.
Infundiranje traja približno eno uro, razen če ni navedeno drugače.
This will tell your doctor how the treatment is working and will also indicate if treatment needs to be continued.
Na ta način bo zdravnik dobil informacijo o učinkovitosti zdravljenja in o tem, ali je treba zdravljenje nadaljevati.
This will usually be in the upper arm.
Navadno je to mišica na nadlakti.
This will usually be in the upper arm.
Običajno je to mišica na nadlahti.
This will usually pass on its own but if it does not, tell your doctor or a nurse as soon as possible.
To običajno mine samo od sebe, če pa ne, povejte svojemu zdravniku.
This will usually pass on its own but if it does not, tell your doctor.
To običajno mine samo od sebe, če pa ne, povejte svojemu zdravniku
This would be about 14 mg or 4 vials (glass bottles) of Replagal for an average size (70 kg) individual.
Za povprečnega človeka (70 kg) je to približno 14 mg ali 4 viale (stekleničke) zdravila Replagal.
This would be clinically relevant for CYP450 substrates with a narrow therapeutic index (e.g. warfarin and phenytoin).
To bi bilo klinično pomembno za substrate CYP450 z ozkim terapevtskim indeksom (npr. varfarin in fenitoin).
This Xarelto 15 mg and 20 mg treatment initiation pack is only for the first 4 weeks of treatment.
To začetno pakiranje zdravila Xarelto 15 mg in 20 mg je samo za prve 4 tedne zdravljenja.
Thisinhibition has not been observed in vivoafter the administration of imatinib 400 mg and paracetamol 1000 mg.
Tega zaviranja po uporabi imatiniba 400 mg in paracetamola 1000 mg in vivo niso opažali.
Thismay cause stomach upset and diarrhoea.
To lahko povzroči želodčne motnje ali drisko.
Thisy can spread around the injection site.
Razširijo se tudi okoli mesta injiciranja.
THORACIC AND
MEDIASTINALNEGA PROSTORA
thoracic and
Občasni
THORACIC AND
PRSNEGA KOŠA IN
thoracic and mediastinal disorders
Bolezni dihal, prsnega koša in mediastinalnega prostora
Thorinane 10,000 IU (100 mg) in 1.0 mL
Thorinane 10.000 i.e. (100 mg) v 1,0 ml
Thorinane 10,000 IU (100 mg) in 1.0 mL solution for injection in pre-filled syringe
Thorinane 10.000 i.e. (100 mg) v 1,0 ml raztopine za injiciranje v napolnjeni injekcijski brizgi
Thorinane 10,000 IU (100 mg) in 1.0 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 10.000 i.e. (100 mg) v 1,0 ml raztopine za injiciranje v napolnjeni injekcijski brizgi natrijev enoksaparinat
Thorinane 2,000 IU (20 mg) in 0.2 mL
Thorinane 2.000 i.e. (20 mg) v 0,2 ml
Thorinane 2,000 IU (20 mg) in 0.2 mL solution for injection in pre-filled syringe
Thorinane 2.000 i.e. (20 mg) v 0,2 ml raztopine za injiciranje v napolnjeni injekcijski brizgi
Thorinane 2,000 IU (20 mg) in 0.2 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 2.000 i.e. (20 mg) v 0,2 ml raztopine za injiciranje v napolnjeni injekcijski brizgi natrijev enoksaparinat
Thorinane 4,000 IU (40 mg) in 0.4 mL
Thorinane 4.000 i.e. (40 mg) v 0,4 ml
Thorinane 4,000 IU (40 mg) in 0.4 mL solution for injection in pre-filled syringe
Thorinane 4.000 i.e. (40 mg) v 0,4 ml raztopine za injiciranje v napolnjeni injekcijski brizgi
Thorinane 4,000 IU (40 mg) in 0.4 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 4.000 i.e. (40 mg) raztopine za injiciranje v napolnjeni injekcijski brizgi natrijev enoksaparinat
Thorinane 4,000 IU (40 mg) in 0.4 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 4.000 i.e. (40 mg) v 0,4 ml raztopina za injiciranje v napolnjeni injekcijski brizgi natrijev enoksaparinat
Thorinane 6,000 IU (60 mg) in 0.6 mL
Thorinane 6.000 i.e. v 0,6 ml
Thorinane 6,000 IU (60 mg) in 0.6 mL solution for injection in pre-filled syringe
Thorinane 6.000 i.e. (60 mg) v 0,6 ml raztopine za injiciranje v napolnjeni injekcijski brizgi
Thorinane 6,000 IU (60 mg) in 0.6 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 6.000 i e. (60 mg) v 0,6 ml raztopine za injiciranje v napolnjeni injekcijski brizgi natrijev enoksaparinat
Thorinane 6,000 IU (60 mg) in 0.6 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 6.000 i.e. (60 mg) v 0,6 ml raztopine za injiciranje v napolnjeni injekcijski brizgi natrijev enoksaparinat
Thorinane 8,000 IU (80 mg) in 0.8 mL
Thorinane 8.000 i.e. (80 mg) v 0,8 ml
Thorinane 8,000 IU (80 mg) in 0.8 mL solution for injection in pre-filled syringe
Thorinane 8.000 i.e. (80 mg) v 0,8 ml raztopine za injiciranje v napolnjeni injekcijski brizgi
Thorinane 8,000 IU (80 mg) in 0.8 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 8.000 i e. (80 mg) v 0,8 ml raztopine za injiciranje v napolnjeni injekcijski brizgi natrijev enoksaparinat
Thorinane 8,000 IU (80 mg) in 0.8 mL solution for injection in pre-filled syringe enoxaparin sodium
Thorinane 8.000 i.e. (80 mg) v 0,8 ml raztopine za injiciranje v napolnjeni injekcijski brizgi natrijev enoksaparinat
Thorinane contains sodium
Zdravilo Thorinane vsebuje natrij
Thorinane has no influence on the ability to drive and use machines.
Zdravilo Thorinane ne vpliva na sposobnost vožnje in upravljanja strojev.
Thorinane is indicated for adults for:
Zdravilo Thorinane je indicirano pri odraslih za:
Thorinane is used in adults to:
Zdravilo Thorinane se uporablja pri odraslih bolnikih za:
Thorinane must not be administered by the intramuscular route.
Zdravila Thorinane ne smete dajati intramuskularno.
Thorinane should not be mixed with any other injections or infusions.
Zdravila Thorinane ne smete mešati z drugimi injekcijami ali infuzijami.
Thorough agitation is necessary to achieve suspension of the vaccine.
Vialo je treba temeljito pretresti, da dosežemo suspendiranje cepiva.
Thoroughly rinse the soap out of the chamber and mouthpiece with warm water.
Komoro in ustnik temeljito splaknite s toplo vodo.
Those effects are described in the cisplatin patient information.
Ti neželeni učinki so navedeni v navodilu za uporabo cisplatina.
Those most frequently reported were nausea (61% of patients), vomiting (59%), febrile neutropaenia (35%), headache (24%), rash (21%), diarrhoea (20%), pruritus (20%), pyrexia (19%), palmar-plantar erythrodysaesthesia syndrome (15%), fatigue (14%), anxiety (12%), mucosal inflammation (11%), and flushing (11%).
Najpogosteje so poročali o navzei (61 % bolnikov), bruhanju (59 %), febrilni nevtropeniji (35 %), glavobolu (24 %), osipu (21 %), diareji (20 %), srbenju (20 %), pireksiji (19 %), sindromu palmarno-plantarne eritrodisestezije (15 %), utrujenosti (14 %), tesnobi (12 %), vnetju sluznice (11 %) in oblivanju (11 %).
Those patients studied all had CD4+ cell counts greater than 250 x 106 cells/l (N = 22; see section 4.5).
Pri vseh preučevanih bolnikih (n = 22) je bilo število celic CD4+ večje od 250 x 106/l (glejte poglavje 4.5).
Those patients switching from 2,000 mg or more of prolonged-release nicotinic acid can initiate Trevaclyn at the 2,000 mg/40 mg dose.
Če bolnik preide na zdravilo Trevaclyn s pripravka nikotinske kisline s podaljšanim sproščanjem, ki ga je jemal v odmerku 2.000 mg ali več, lahko zdravilo Trevaclyn začne jemati v odmerku
Those receiving the compressed regimen (0, 1, 2 months dosing schedule) must receive the 12 month booster to induce higher antibody titres.
Dojenčki, ki so cepljeni po skrajšani shemi (shema cepljenja 0, 1, 2 meseca), morajo po 12 mesecih dobiti še obnovitveni odmerek, ki izzove višji titer protiteles.
Those serious adverse reactions attributed to TRISENOX included APL differentiation syndrome (3), leukocytosis (3), prolonged QT interval (4, 1 with torsade de pointes), atrial fibrillation/atrial flutter (1), hyperglycaemia (2) and a variety of serious adverse reactions related to haemorrhage, infections, pain, diarrhoea, nausea.
Med resne neželene reakcije, ki so jih pripisali zdravilu TRISENOX, so spadali sindrom diferenciacije APL (3), levkocitoza (3), podaljšan interval Q-T (4, 1 z aritmijo torsade de pointes), atrijska fibrilacija/atrijska undulacija (1), hiperglikemija (2) in razne resne neželene reakcije, povezane s hemoragijo, okužbami, bolečinami, drisko in navzeo.
Those signs are usually transient and disappear within 24 hours of the application; if they take longer to disappear consult your veterinarian.
Ti znaki so običajno prehodni in izginejo v 24 urah po nanosu; če po tem času ne izginejo, se posvetujte s svojim veterinarjem.
those trials, a total of 1102 subjects received 60 mg of ospemifene and 787 subjects received placebo.
V teh preskušanjih je skupaj 1.102 oseb prejemalo 60 mg ospemifena in 787 oseb je prejemalo placebo.
Those which have not yet been entered should be reported in the following S- PSUR.
Tiste, ki še niso bili vneseni, je treba prijaviti v naslednjem S-PSUR.
Though efficacy may not be complete, imepitoin is considered to be a suitable treatment option in some dogs because of its safety profile.
Čeprav učinkovitost morda ni popolna, je imepitoin primeren za zdravljenje pri nekaterih psih zaradi njegovega varnostnega profila.
Though less potent than naltrexone,
Čeprav je šibkejši od naltreksona, se
Though rare, seizures may occur in dogs treated with Reconcile.
Pri psih, zdravljenih z zdravilom Reconcile, lahko pride do napadov krčev, čeprav redko.
Though rare, seizures may occur in dogs treated with Reconcile.
V redkih primerih lahko psi, ki se jim daje, Reconcile doživljajo napade krčev.
Though the number of patients included was limited and with high variability, these data indicate a marked increase in the exposure to bosentan and its primary metabolite Ro 48-5033 in patients with moderate liver function impairment (Child-Pugh class B).
Čeprav je bilo število vključenih bolnikov omejeno in so se med seboj močno razlikovali, nakazujejo ti podatki na veliko povešanje izpostavljenosti bosentanu in njegovemu primarnemu presnovku Ro 48-5033 pri bolnikih z zmerno okvaro delovanja jeter (razred B po klasifikaciji Child-Pugh).
Thoughts about committing suicide
misli o tem, da bi naredili samomor,
Thoughts about committing suicide.
razmišljanja, da bi naredili samomor,
Thoughts about committing suicide.
razmišljanja, da bi naredili samomor.
thoughts about suicide
amomorilne misli,
Thoughts about suicide or hurting yourself
razmišljanje o samomoru ali samopoškodovanju
thoughts about threatening the life of others,
misli kako ogroziti življenja drugih,
thoughts about threatening the life of others.
misli, kako ogroziti življenja drugih.
Thoughts of harming yourself or suicide
Razmišljanje o samopoškodovanju ali samomoru
Thoughts of suicide and worsening of depression or anxiety disorder
Misli na samomor in poslabšanje depresije ali anksiozne motnje
thoughts of suicide, suicide attempt and suicide,
misli na samomor, poskus samomora in samomor,
thoughts of suicide, suicide attempt and suicide;
razmišljanje o samomoru; poskus samomora in samomor;
threaded needle connector
navojni priključek za iglo
threatening (grade
življenjsko
threatening (grade 3-
življenjsko
threatening events, including coma
nevarnih dogodkov, vključno s
Three (3) patients with HES and CEL associated with PDGFR gene re-arrangements were reported in 3 publications.
3 publikacijah so objavljeni podatki treh (3) bolnikov s HES oziroma CEL s preureditvijo gena za PDGFR.
Three (3) patients with HES and CEL associated with PDGFR gene re-arrangements were reported in 3 publications.
V 3 publikacijah so objavljeni podatki treh (3) bolnikov s HES in CEL s preureditvijo gena za PDGFR.
Three (3)patients with HES and CEL associated with PDGFR gene re-arrangements were reported in 3publications.
3 publikacijah so objavljeni podatki treh (3) bolnikov s HES oziroma CEL s preureditvijo gena za PDGFR.
Three (<1%) out of 409 patients in the degarelix group and four (2%) out of 201 patients in the leuprorelin 7.5 mg group, had a QTcF ≥ 500 msec.
Trije (<1 %) od 409 bolnikov v skupini z degareliksom in štirje (2 %) od 201 bolnikov v skupini, zdravljeni z levprorelinom v odmerku 7,5 mg, so imeli QTcF ≥ 500 msek.
Three 1 mg blisters should not be substituted for one 3 mg blister (see section 2, “Take special care with EXUBERA” and section 3, “How to take EXUBERA”).
Enega 3-mg pretisnega omota ne smete nadomestiti s tremi 1-mg (glejte poglavje 2 “Bodite posebno pozorni pri uporabi zdravila EXUBERA” in poglavje 3 “Kako uporabljati zdravilo EXUBERA”).
Three 1 mg unit dose blisters should not be substituted for one 3mg blister (see section 2, “Take special care with EXUBERA”, section 3, “How to take EXUBERA” and section 6 “Further information”).
Enega 3-mg pretisnega omota ne smete nadomestiti s tremi 1-mg pretisnimi omoti (glejte poglavje 2 “Bodite posebno pozorni pri uporabi zdravila EXUBERA”, poglavje 3 “Kako uporabljati zdravilo EXUBERA” in poglavje 6 “Dodatne informacije”).
Three 320 mg/40 mg tablets a day
Tri 320 mg/40 mg tablete na dan
Three 5 mg tablets
Tri 5 mg tablete
Three additional studies looked at the use of the medicine in the prevention of bleeding and in surgery in patients with severe or moderately severe haemophilia A, including one study in 53 children under the age of six years.
V treh dodatnih študijah so proučevali uporabo zdravila pri preprečevanju krvavenja ter njegovo uporabo med kirurškimi posegi pri bolnikih s hudo ali zmerno obliko hemofilije A, vključno z eno študijo pri 53 otrocih, mlajših od šest let.
Three additional studies were carried out to show that the active substances were absorbed in the body in the same way when they taken as separate tablets and as Rasilez HCT.
Izvedene so bile tri dodatne študije, s katerimi je bilo dokazano, da sta se zdravilni učinkovini absorbirali v telo enako, če sta bili vzeti v obliki ločenih tablet ali kot zdravilo Rasilez HCT.
Three clinical studies were conducted in 1054 patients in an at-home setting to define the period of responsiveness to CIALIS on demand.
Opravljene so bile tri klinične študije za določitev obdobja odzivnosti na zdravilo CIALIS zaužit po potrebi, v katerih je bilo vključenih 1054 bolnikov v domačem okolju.
Three clinical studies were conducted in 1054 patients in an at-home setting to define the period of responsiveness to CIALIS.
Opravljene so bile tri klinične študije za določitev obdobja odzivnosti na zdravilo CIALIS, v katerih je bilo vključenih 1054 bolnikov v domačem okolju.
Three clinical trials have been conducted in children and adolescents; two with standard interferon and ribavirin and one with pegylated interferon and ribavirin.
Opravljena so bila tri klinična preskušanja pri otrocih in mladostnikih, dva s standardnim interferonom in ribavirinom in eno s pegiliranim interferonom in ribavirinom.
Three clinical trials were performed with Flebogamma DIF, one for replacement therapy in patients with primary immunodeficiency (in both adults and in children above 6 years) and two for immunomodulation, in patients with immune thrombocytopenic purpura (one in adult patients and another in both adult and children between 3 and 16 years).
Z zdravilom Flebogamma DIF so izvedli tri klinična preskušanja, eno kot nadomestno zdravljenje pri bolnikih s primarno imunsko pomanjkljivostjo (pri odraslih in pri otrocih, starih nad 6 let), in dve kot imunomodulacijo pri bolnikih z imunsko trombocitopenično purpuro (eno pri odraslih bolnikih, drugo pa pri odraslih in pri otrocih, starih od 3 do 16 let).
Three days before the infusion, a procedure called leukapheresis is performed to collect immune cells from the patient’s blood, and these are then sent to a manufacturing facility to prepare the medicine.
Tri dni pred infundiranjem se opravi postopek, imenovan levkafereza, s katerim se iz bolnikove krvi pridobijo imunske celice, ki se nato pošljejo v proizvodni obrat, kjer pripravijo zdravilo.
Three different doses of Ariclaim were compared with placebo.
Tri različne odmerke zdravila Ariclaim so
Three different doses of the medicine (10, 15 or 20 mg/day) were compared with placebo (a dummy treatment).
Pri tem so tri različne odmerke (10, 15 ali 20 mg na dan) primerjali s placebom (zdravilom brez zdravilne učinkovine).
Three dogs had seizure-like activity ; however, relation to treatment could not be established.
Trije psi so kazali aktivnost podobno seizmičnim krčem toda povezava z zdravljenjem ni bila dokazana.